LENITO NAVARRO: Open Payments
NPI 1508039199 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,048 in 32 payments from 13 companies in 2025. Trend: 2023 $591 · 2024 $610 · 2025 $1,048
Food & beverage: $1,048
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $213 |
| Syndax Pharmaceuticals, Inc. | 1 | $147 |
| Merck Sharp & Dohme LLC | 4 | $116 |
| AstraZeneca Pharmaceuticals LP | 5 | $115 |
| Celgene Corporation | 4 | $93 |
| BeOne Medicines USA, Inc. | 3 | $90 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| ABBVIE INC. | 2 | $54 |
| PharmaEssentia USA Corporation | 2 | $38 |
| Rigel Pharmaceuticals, Inc. | 1 | $30 |
Products named: REVUFORJ, RYBREVANT, CALQUENCE, BRUKINSA, KEYTRUDA, LYNOZYFIC, TALVEY, BREYANZI.
Industry payments across CA — which companies pay providers there.
